Therapeutic approach to difficult-to-treat multidrug-resistant enterococcal infections
Open Access
- 1 October 2025
- journal article
- review article
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 69 (10) , e0106024
Abstract
Difficult-to-treat (DTR) enterococcal infections, particularly those caused by multidrug-resistant Enterococcus faecium and Enterococcus faecalis , pose significant clinical challenges due to limited treatment options and high rates of treatment failure, compounded by a paucity of new antimicrobial agents in the development pipeline. Despite advances in understanding resistance mechanisms and in vitro synergistic antibiotic combinations, robust clinical data to guide therapy for severe or DTR enterococcal infections remain limited. This review synthesizes available evidence to inform optimal management strategies, including drug selection and dosing, while highlighting areas needing further research. Given the ongoing threat posed by multidrug-resistant enterococci, we emphasize the importance of gathering robust clinical data to guide best practices for managing these difficult-to-treat infections.Keywords
Funding Information
- National Health and Medical Research Council (GNT1185213)
- National Health and Medical Research Council (GNT1196103)
- National Institute of Allergy and Infectious Diseases (K24AI121296, R01AI134637, R01AI148342, P01AI152999)
- National Institute of Allergy and Infectious Diseases (K08AI135093, R21AI175821)
This publication has 105 references indexed in Scilit:
- Risk factors and outcome associated with the acquisition of MDR linezolid-resistant Enterococcus faecium: a report from tertiary care centreEuropean Journal of Clinical Microbiology & Infectious Diseases, 2024
- Successful treatment of complicated infective endocarditis due to Enterococcus faecium in a patient with substance use disorder using oritavancin as sequential maintenance therapyClinical Microbiology and Infection, 2024
- Isolation and characterization of a novel lytic bacteriophage vB_Efm_LG62 infecting Enterococcus faeciumVirus Genes, 2023
- The Combination of Daptomycin with Fosfomycin is More Effective than Daptomycin Alone in Reducing Mortality of Vancomycin-Resistant Enterococcal Bloodstream Infections: A Retrospective, Comparative Cohort StudyInfectious Diseases and Therapy, 2023
- Contezolid: First ApprovalDrugs, 2021
- Daptomycin in the treatment of enterococcal bloodstream infections and endocarditis: a EUCAST position paperClinical Microbiology and Infection, 2020
- Update on prevalence and mechanisms of resistance to linezolid, tigecycline and daptomycin in enterococci in Europe: Towards a common nomenclatureDrug Resistance Updates, 2018
- Cooperating Commensals Restore Colonization Resistance to Vancomycin-Resistant Enterococcus faeciumCell Host & Microbe, 2017
- In vitro activity of tedizolid against linezolid-resistant staphylococci and enterococciDiagnostic Microbiology and Infectious Disease, 2016
- Peptide antibiotics in action: Investigation of polypeptide chains in insoluble environments by rotational-echo double resonanceBiochimica et Biophysica Acta (BBA) - Biomembranes, 2006